17:15 EDT Checkpoint Therapeutics files to sell 6.2M shares of common stock for holders
Elevate Your Investing Strategy:
- Take advantage of TipRanks Premium at 50% off! Unlock powerful investing tools, advanced data, and expert analyst insights to help you invest with confidence.
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on CKPT:
- Checkpoint Therapeutics price target lowered to $20 from $34 at H.C. Wainwright
- Checkpoint Therapeutics Reports Second Quarter 2024 Financial Results and Recent Corporate Updates
- Checkpoint Therapeutics reports Q2 EPS (18c) vs ($1.05) last year
- Checkpoint announces FDA acceptance of BLA resubmission for cosibelimab
- Checkpoint Therapeutics Announces FDA Acceptance of BLA Resubmission of Cosibelimab for the Treatment of Advanced Cutaneous Squamous Cell Carcinoma